Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating immunogenicity and safety of GSK's HBV-MPL vaccine given in 2-dose schedule versus Engerix-B given in a 3-dose schedule in healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• HBV-MPL vaccine (HBV-MPL vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED